Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized Trial of PCSK9 Inhibitors in Calcific Aortic Valve Stenosis

NCT04968509 is registered in ClinicalTrials.gov with Beijing Anzhen Hospital as lead sponsor.

NCT NCT04968509
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04968509 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized Trial of PCSK9 Inhibitors in Calcific Aortic Valve Stenosis
Lead sponsor
Beijing Anzhen Hospital
Phase
Phase 3
Overall status
Recruiting
Start date
March 22, 2024
Completion date
January 31, 2028
Enrollment
160 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

aortic stenosis